Composition of the nonesterified fatty acids and lipid peroxidation in metabolic syndrome;Složení esterifikovaných mastných kyselin a lipoperoxidace u metabolického syndromu

Casopis Lekaru Ceskych

Volumn 146, Issue 5, 2007, Pages 484-491

  Zak A ^a,b   Vecka, M ^a   Tvrzicka E ^a   Jachymova M ^a   Dusejovska M ^a   Janikova L ^a   Stankova B ^a   Vavrova L ^a   Kodydkova J ^a   Zeman, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Ústav Klinické Biochemie a Laboratorní Diagnostiky 1 LF UK A VFN ^*  (Czech Republic)

Author keywords

Desaturase and elongase activity; Fatty acid composition; Gene polymorphisms; Metabolic syndrome; Oxidative stress

Indexed keywords

FATTY ACID;

ADULT; ARTICLE; BLOOD; FEMALE; GENETICS; HUMAN; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS;

ADULT; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS;

EID: 34249323010     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Grundy, S. M.: Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nature Review, 2006, 5, s. 295-304.
2. Gotto, A. M., Jr., Pownall, H. J.: Manual of lipid disorders. 3rd ed., Philadelphia, Lippincott Williams Wilkins, 2003, 482 s.
3. Lewis, G. F., Carpentier, A., Adeli, K. et al.: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type I diabetes. Endocr. Rev., 2002, 23, s. 201-229.
4. Evans, J. L., Goldfine, I. D., Maddux, B. A. et al.: Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Rev., 23, 2002, s. 599-622.
5. Laakso, M.: Gene variants, insulin resistance, and dyslipidaemia. Curr. Opin. Lipidol., 2004, 15, s. 115-120.
6. Bray, G. A., Paeratakul, S., Popkin, B. M.: Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol. Behav., 2004, 83, s. 549-555.
7. Riccardi, G., Giacco, R., Rivellese, A. A.: Dietary fat, insulin sensitivity and the metabolic syndrome. Clin. Nutr., 2004, 23, s. 447-456.
8. Vessby, B.: Dietary fat, fatty acid composition in plasma and the metabolic syndrome and the metabolic syndrome. Curr. Opin. Lipidol., 2003, 14, s. 15-19.
9. Decsi, T., Csábi, G., Török, K., et al.: Polyunsaturated fatty acids in plasma lipids of obese children with and without metabolic cardiovascular syndrome. Lipids, 2000, 35, s. 1179-1184.
10. Leskinen, M. H., Solakivi, T., Kunnas, T. et al.: Serum fatty acids in postinfarction middle-aged men. Scand. J. Clin. Lab. Med., 2005, 65, s. 485-490.
11. Klein-Platat, C., Drai, J., Oujaa, M. et al.: Plasma fatty acid composition is associated with the metabolic syndrome and low grade inflammation in overweight adolescent. Am. J. Clin. Nutr., 2005, 82, s. 1178-1184.
12. Okada, T., Furuhashi-Sato, N., Kuromori, Y. et al.: Theencoding allele homozygosity at codon 54 of FABP 2 gene my be associate with impaired delta 6 desaturase activity and reduced plasma arachidonic acid in obese children. J. Atheroscl. Thromb., 2006, 13, s. 192-196.
13. Vindgren, H. M., Sipiläinen, R. H., Heikkinen, S. et al.: Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Europ. J. Clin. Invest., 1997, 27, s. 405-408.
14. Alberti, K. G., Zimmet, P., Shaw, J.: Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006, 23, s. 469-480.
15. Kunešová, M., Hainer, V., Tvrzická, E. et al.: Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids, 2002, 37, s. 27-32.
16. Lochman, T., Roche, A., Martorel, R. (eds.): Standardization of anthropometric measurements. Human Kinetics Publishers, Champaign, IL, 1989, s. 39-80.
17. Durnin, J. V., Womersley, J.: Body fat assessed from the total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 71 years. Brit. J. Nutr., 1974, 32, s. 77-97.
18. Matthews, D. R., Hosker, J. P., Rudenski, A. S. et al.: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985, 28, s. 412-419.
19. Ahotupa, M., Ruutu, M., Mantyla, E.: Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin. Biochem. 1996, 29, s. 139-144.
20. Žák, A., Zeman, M., Tvrzická, E. et al.: Složení mastných kyselin a parametry lipoperoxidace VLDL a LDL u osob s dyslipidémií. Cas. Lék. ces. 2000, 139, s. 18-24.
21. Tvrzická, E., Vecka, M., Staňková, B., Žák, A.: Analysis of fatty acids in plasma lipoproteins by gas chromatographyflame ionisation detection. Quantitative aspects. Anal. Chim. Acta, 2002, 465, s. 337-350.
22. Miller, S. A., Dykes, D. D., Polesky, H. F.: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res., 1988, 16, s. 1215.
23. Hixson, J. E., Vernier, D. T.: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J. Lipid Res., 1990, 31, s. 545-548.
24. Jáchymová, M., Horký, K., Bultas, J. et al.: Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem. Biophys. Res. Commun., 2001, 284, s. 426-430.
25. Damcott, C. M., Feingold, E., Barmana, M. M. et al.: Variation in the FABP2 promotor alter transcriptional activity and is associated with body composition and plasma lipid levels. Hum. Genet. 2003, 112, s. 610-616.
26. Yen, C. H. J., Beamer, B. A., Negri, C. et al.: Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPAR γ) gene diabetic Caucasians: Identification of a Pro12Ala PPAR γ2 missense mutation. Biochem. Biophys. Res. Commun., 1997, 241, s. 270-274.
27. Dixon, W. J.: BMDP statistical software manual, vol. 1-2. Los Angeles, CA, USA, Berkeley, University of California Press, 1992.
28. Warensjö, E., Sundsröm, J., Lind, L. et al.: Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am. J. Clin. Nutr., 2006, 84, s. 442-448.
29. Aarsland, A., Chirkes, D., Wolfe, D. R.: Hepatic and wholebody fat synthesis in humans during carbohydrate overfeeding. Am. J. Clin. Nutr. 1997, 65, s. 1774-1782.
30. Lindgärde, F., Vessby, B., Ahrén, B.: Serum cholesteryl fatty acid composition and plasma glucose concentrations in American women. Am. J. Clin. Nutr. 2006, 84, s. 1009-1013.
31. Laaksonen, D. E., Lakka, T. A., Lakka, H.-M. et al.: Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet. Med., 2002, 19, s. 456-464.
32. Tammi, A., Ronnemaa, T., Rask-Nissila, L., et al.: Apolipoprotein E phenotype regulates cholesterol absorption in healthy 13-month-old children. The STRIP Study. Pediat. Res. 2001, 50, s. 688-691.
33. Levy, E., Menard, D., Delvin, E. et al.: The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J. Biol. Chem., 2001, 276, s. 39679-39684.
34. Baier, L. J., Sacchettini, J. C., Knowler, W. C. et al.: An amino acid substitution in the human intestinal fatty acid binding protein in associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest., 95, 1995, s. 1281-1287.
35. Renner, W., Pressl, H., Wascher, T. C. et al.: The role of the A54T polymorphism of the intestinal fatty acid binding protein for lipid levels, insulin sensitivity and carotid atherosclerosis. Atherosclerosis, 2004, 173, s. 137-139.
36. Li, S., Chen, W., Srinivasan, S. R. et al.: The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study. Diabetes, 2003, 52, s. 1265-1269.
37. Yazu, K., Yamomoto, Y., Ukegawa, K., Niki, E.: Mechanism of lower oxidability of eicosapentaenoate than linoleate in aqueous micelles. Lipids, 1996, 31, s. 337-340.
38. Fujita, K., Nishozawu, H., Funahashi, T. et al.: Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ. J., 2006, 70, s. 1437-1442.
39. Cushman, M., Arnold, A. M., Psaty, B. M. et al.: C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation, 2005, 112, s. 25-31.
40. Furukawa, S., Fujita, T., Shimabukuro, M. et al.: Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 2004, 114, s. 1752-1161.